PRLD - H.C. Wainwright cuts Prelude Therapeutics to neutral cites valuation
2024-02-21 17:29:54 ET
More on Prelude Therapeutics
- Prelude Therapeutics: Interesting Pipeline That Is Too Early To Warrant My Buy
- Prelude Therapeutics: Scientifically Interesting Oncology Company With Preclinical Data
- Seeking Alpha’s Quant Rating on Prelude Therapeutics
- Historical earnings data for Prelude Therapeutics
- Financial information for Prelude Therapeutics